|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
Walgreen Company 8-K 2010 SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): February 23, 2010
![]() WALGREEN
CO.
(Exact
name of registrant as specified in its charter)
Registrant’s
telephone number, including area code: (847) 940-2500
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
On
February 23, 2010, Stanley B. Blaylock, senior vice president of Walgreen Co.
(the “Company”) and president of Walgreens Health Services, informed the Company
that he will leave the Company in April after a transition
period. The exact date of Mr. Blaylock’s departure and the material
terms and conditions of any agreement between the Company and Mr. Blaylock have
not yet been determined and will be described in an amendment to this current
report.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||